Cited 17 times in
Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박준성 | - |
dc.contributor.author | 정희철 | - |
dc.contributor.author | 박형순 | - |
dc.contributor.author | 윤동섭 | - |
dc.contributor.author | 이동기 | - |
dc.contributor.author | 이민구 | - |
dc.contributor.author | 이세준 | - |
dc.contributor.author | 박지수 | - |
dc.date.accessioned | 2017-02-27T08:27:07Z | - |
dc.date.available | 2017-02-27T08:27:07Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1598-2998 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/147187 | - |
dc.description.abstract | PURPOSE: This study focused on implementation of a prognostic scoring index based on clinico-laboratory parameters measured routinely on admission in metastatic pancreatic cancer patients. MATERIALS AND METHODS: Records from 403 patients of metastatic disease were analyzed retrospectively. Continuous variables were dichotomized according to the normal range or the best cut-off values statistically determined by Contal and O'Quigley method, and then analyzed in association with prognosis-overall survival (OS), using Cox's proportional hazard model. Scores were calculated by summing the rounded chi-square scores for the factors that emerged in the multivariate analysis. RESULTS: Performance status, hemoglobin, leucocyte count, neutrophil-lymphocyte ratio, and carcinoembryonic antigen were independent factors for OS. When patients were divided into three risk groups according to these factors, median survival was 11.7, 6.2, and 1.3 months for the low, intermediate, and high-risk groups, respectively (p < 0.001). Palliative chemotherapy has a significant survival benefit for low and intermediate-risk patients (median OS; 12.5 months vs. 5.9 months, p < 0.001 and 8.0 months vs. 2.0 months, p < 0.001, respectively). CONCLUSION: We advocate the use of a multivariable approach with continuous variables for prognostic modeling. Our index is helpful in accurate patient risk stratification and may aid in treatment selection. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English, Korean | - |
dc.publisher | Official journal of Korean Cancer Association | - |
dc.relation.isPartOf | CANCER RESEARCH AND TREATMENT | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adenocarcinoma/blood | - |
dc.subject.MESH | Adenocarcinoma/diagnostic imaging | - |
dc.subject.MESH | Adenocarcinoma/pathology* | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Brain Neoplasms/diagnostic imaging | - |
dc.subject.MESH | Brain Neoplasms/pathology* | - |
dc.subject.MESH | Brain Neoplasms/secondary | - |
dc.subject.MESH | Carcinoembryonic Antigen/blood | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Leukocyte Count | - |
dc.subject.MESH | Lymphocytes/pathology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neoplasm Metastasis | - |
dc.subject.MESH | Neutrophils/pathology | - |
dc.subject.MESH | Pancreatic Neoplasms/blood | - |
dc.subject.MESH | Pancreatic Neoplasms/diagnostic imaging | - |
dc.subject.MESH | Pancreatic Neoplasms/pathology* | - |
dc.subject.MESH | Prognosis* | - |
dc.subject.MESH | Proportional Hazards Models | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Severity of Illness Index* | - |
dc.title | Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma. | - |
dc.type | Article | - |
dc.publisher.location | Korea | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Surgery | - |
dc.contributor.googleauthor | Hyung Soon Park | - |
dc.contributor.googleauthor | Hye Sun Lee | - |
dc.contributor.googleauthor | Ji Soo Park | - |
dc.contributor.googleauthor | Joon Seong Park | - |
dc.contributor.googleauthor | Dong Ki Lee | - |
dc.contributor.googleauthor | Se-Joon Lee | - |
dc.contributor.googleauthor | Dong Sup Yoon | - |
dc.contributor.googleauthor | Min Goo Lee | - |
dc.contributor.googleauthor | Hei-Cheul Jeung | - |
dc.identifier.doi | 10.4143/crt.2015.400 | - |
dc.contributor.localId | A01672 | - |
dc.contributor.localId | A03794 | - |
dc.contributor.localId | A02548 | - |
dc.contributor.localId | A02723 | - |
dc.contributor.localId | A02781 | - |
dc.contributor.localId | A02882 | - |
dc.contributor.localId | A04576 | - |
dc.relation.journalcode | J00453 | - |
dc.identifier.eissn | 2005-9256 | - |
dc.relation.journalsince | 2001~ | - |
dc.identifier.pmid | 26875200 | - |
dc.relation.journalbefore | ~2001 Journal of the Korean Cancer Research Association (대한암학회지) | - |
dc.subject.keyword | Pancreatic neoplasms | - |
dc.subject.keyword | Prognosis | - |
dc.subject.keyword | Research design | - |
dc.subject.keyword | Survival | - |
dc.contributor.alternativeName | Park, Joon Seong | - |
dc.contributor.alternativeName | Jeung, Hei Cheul | - |
dc.contributor.alternativeName | Park, Hyung Soon | - |
dc.contributor.alternativeName | Yoon, Dong Sup | - |
dc.contributor.alternativeName | Lee, Dong Ki | - |
dc.contributor.alternativeName | Lee, Min Goo | - |
dc.contributor.alternativeName | Lee, Se Joon | - |
dc.contributor.affiliatedAuthor | Park, Joon Seong | - |
dc.contributor.affiliatedAuthor | Jeung, Hei Cheul | - |
dc.contributor.affiliatedAuthor | Yoon, Dong Sup | - |
dc.contributor.affiliatedAuthor | Lee, Dong Ki | - |
dc.contributor.affiliatedAuthor | Lee, Min Goo | - |
dc.contributor.affiliatedAuthor | Lee, Se Joon | - |
dc.contributor.affiliatedAuthor | Park, Hyung Soon | - |
dc.citation.volume | 48 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1253 | - |
dc.citation.endPage | 1263 | - |
dc.identifier.bibliographicCitation | CANCER RESEARCH AND TREATMENT, Vol.48(4) : 1253-1263, 2016 | - |
dc.date.modified | 2017-02-24 | - |
dc.identifier.rimsid | 47604 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.